Insider trades
Golden Lee Scott, Chief Officer of PTC Therapeutics PTCT, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 04/02.
Golden Lee Scott
EVP & Chief Medical Officer
- Company
- PTC Therapeutics PTCT
- First filing
- 24/01/10
- Trades
- 23 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$1.1M
- Last trade
- 04/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 04/02 | 04/06 | 829 sh | $67.99 | $56,363.71 | −1.0% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 03/05 | 03/09 | 10,000 sh | $63.38 | $633,800 | −11.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 02/18 | 02/20 | 2,484 sh | $69.36 | $172,290.24 | −2.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 01/08 | 01/12 | 866 sh | $76.45 | $66,205.7 | −0.9% |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 1,982 sh2 trades | $77.12avg. | $152,855.16 | −2.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/04/02 | 25/04/04 | 897 sh | $46.95 | $42,114.15 | −1.2% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 1,757 sh2 trades | $50.11avg. | $88,044.94 | −2.2% |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 2,008 sh2 trades | $44.84avg. | $90,036.4 | −2.5% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/05/07 | 24/05/08 | 175 sh | $32.82 | $5,743.5 | −0.3% |
PTC TherapeuticsPTCT | Open-market sale | 24/04/02 | 24/04/04 | 526 sh | $28.37 | $14,922.62 | −0.9% |
PTCT | Open-market sale10b5-1 plan | 24/01/08–24/01/09 | 24/01/10 | 2,000 sh2 trades | $28.87avg. | $57,733.25 | −5.0% |